CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Explore the essentials of the W-8BEN form for non-US residents with ETF dividends, including who qualifies and how it reduces tax withholding.
14,027 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Sandisk leads the 2026 market rally, with outsized gains that eclipse every other S&P 500 stock. Analysts weigh how l...
A wave of quantum funding is moving beyond labs to big-name backers. BlackRock, Nvidia, and Temasek are leading a sur...
June brought a momentum burst in niche tech, led by space-based connectivity. This article breaks down the stock mark...
The Financial Conduct Authority published its final crypto rulebook on June 30, 2026, signaling a formal licensing re...
OCBC unveils an AI-driven avatar banking platform featuring two virtual advisors, Wendy and Wayne. The bank says the ...
The White House signals a pivot from extending USMCA to pursuing bilateral agreements with Canada and Mexico, with a ...
The June payroll gain came in at 57,000, with the unemployment rate slipping to 4.2%. Revisions to April and May pain...
AMD has surged about 140% year-to-date, powered by AI infrastructure demand. Three catalysts are driving the rally to...
Two high-profile guests showed up in identical gowns at a celebrity wedding, highlighting how fashion choices mirror ...
Private AI leaders OpenAI and Anthropic see valuations near $1 trillion as investors chase growth. A cooling IPO wind...
A dramatic World Cup night in Mexico reveals more than a scoreline. Learn how fans can translate the energy of a big ...